Dr Patrick Finn
Paddy received his PhD under the supervision of Tom Brown in 1996 for research investigating Peptide Nucleic Acid/DNA hybrid oligonucleotides and their physical properties. After a series of scientific positions within Amersham International in the UK and US he moved to Invitrogen to drive new product development initiatives in their molecular biology business. Post-Invitrogen he was Director of Product Development for Beckman Coulter Molecular Diagnostics and is now Director of Business Development for Agilent Technologies encompassing their Life Sciences business. He has also served on the Scientific Advisory Board of Enzymatic, a thriving reagent company headquartered in Beverly, MA.